Summary
Phototherapy results in the conversion of bilirubin to more water-soluble isomers. Six clinically used phototherapy lamps which differ in their emission spectra have been compared in their ability to produce configurational and structural isomers of bilirubin in vitro. For all of the lamps, the initial rate of configurational isomerization was highly correlated ( r = 0.969) with the intensity of irradiation falling within the bilirubin absorption band. The percentage of the total bilirubin converted to the configurational isomer at equilibrium was dependent upon the spectral distribution of the lamp, and was greatest (26.2 + 1.3%) with the special blue lamp, which has a narrow spectral output centered at 445 nm. The rate of formation of the structural isomer, lumirubin, was generally dependent upon the intensity of irradiation within the bilirubin absorption band.
Abbreviation

HEPES, N-2-Hydroxyethylpiperazine-N'-2-ethanesulfonic acid
Despite the widespread use of phototherapy for the prevention and treatment of neonatal jaundice, debate continues over the most effective light source (2, 6, [15] [16] [17] [18] [19] . Thus, several phototherapy units which differ in spectral distribution and intensity have been recommended. These recommendations are based on empirical studies which compared the effect of different light sources on serum bilirubin concentration in jaundiced infants (1 5-1 9) or congenitally jaundiced Gunn rats (2). A limitation of such studies is that the measured effect of phototherapy, i.c. decline in serum bilirubin, is a secondary and delayed response (3, 10) (Ennever, Knox, Denne, and Speck, submitted). The primary effect of the treatment is rapid conversion of bilirubin to excretable photoproducts (8, 13, 14) (Ennever et al., submitted). These include yellow compounds which are isomers of bilirubin (i.e. which have the same chemical formula) (1 1, 13).
The decline in serum bilirubin requires transport of these photoisomers from their site of formation to the liver where they are excreted in the bile (14) . Recent studies have shown that the rates of excretion of these photoproducts are different in the hbman newborn infant than in the Gunn rat (14) (Ennever et ul., submitted). Therefore, data derived from the Gunn rat on the relative efficacy of various phototherapy lamps may not be directly applicable to the human neonate.
Previous studies have shown that, during phototherapy of jaundiced infants or irradiation of bilirubin-human albumin solutions in vitro, the most rapid photochemical reaction is the formation of a configurational isomer of bilirubin, designated as 4Z,15E-bilirubin (8, 12) . When the reaction is canied out in vitro, an equilibrium is eventually established between the natural 4 2 , 1 5 2 form and the 4Z,15E isomer (6, 12 ). An additional photochemical reaction, which occurs at a slower rate both in vitro and in vivo, is the formation of a structural isomer, designated lumirubin (1 1) (Ennever et a/., submitted). Recently, we have shown that both the rate of formation (4) and the equilibrium concentration (6) of the 4Z, 15 E configurational isomer produced by monochromatic irradiation in vitro is highly wavelength dependent. It is difficult to extrapolate these results to the broad spectrum lights commonly used in phototherapy. Therefore, we have selected several phototherapy lamps that differ in their spectral emission characteristics and have compared their ability to produce configurational and structural isomers of bilirubin in vitro. These data provide the background necessary for similar comparative studies in jaundiced infants.
MATERIALS AND METHODS
Bilirubin (Sigma Chemical Co., St Louis, MO), purified as previously described (9) , was dissolved in 0.01 M NaOH and added to a solution of human serum albumin (fatty acid free, Sigma) in 0.15 M NaCl 0.05 M HEPES, pH 7.5. After addition of the alkaline bilirubin solution, the pH of the solution was restored to 7.4 by the addition of 0.01 M HCI. Final concentrations were 44 pM bilirubin and 88 pM albumin.
Five of the light sources were fluorescent lamps (20 watt): special blue (Westinghouse F20T12/BB), blue (Sylvania F20T12/B), daylight (Sylvania F20T12/DA), green (Sylvania F20T12/G), and Vita-Lite (DuroTest). Before use, the lamps were aged for 100 h to obtain a stable spectral output (7). The one additional light source was a Cavitron PT 1400 phototherapy unit containing a tungsten-halogen filament lamp (General Electric type ENH).
Fifteen-milliliter samples of the bilirubin-albumin solution were placed in 30-ml plastic culture flasks (Costar, Cambridge, resultin^ in^ in a 3 . 5 .~ 3.5 X 1.3 cm volume of liquid. samples were irradiated normal to the square surface, positioned 50 cm from either a bank of eight fluorescent lamps in a standard phototherapy canopy or from a single tungsten-halogen lamp. During irradiation, the samples were magnetically stirred and thermostated to 20°C. Aliquots were removed at timed intervals and the formation of bilirubin photoproducts was followed by high pressure liquid chromatography on a 0.46 X 25 cm ZorbaxODs column (Dupont Co., Wilmington DE) fitted with a precolumn. The eluant was 0.1 M di-n-octylamine acetate in methanol, pH 7.7 (12) . Chromatography was performed on a Varian model 5060 liquid chromatograph equipped with a model UV-100 detector (Varian Associates, Walnut Creek, CA) set at 465 nm and a Hewlett-Packard (Avondale, PA) model 3390A reporting integrator. The integrated peak areas were not corrected for differences in the 465-nm extinction coefficient among the various bilirubin isomers.
Emission spectra of the lamps were recorded on Cary model 1 18 or 2 10 spectrophotometers (Varian Associates). Emission spectra were recorded in the single beam mode with the phototherapy lamps substituted for the spectrophotometer light source. Irradiance at 50 cm was measured normal to each lamp with an International Light model IL700 radiometer and a SEE 400 broad-band detector fitted with a filter (type TBLU, International Light) which transmitted light between 350 and 530 nm. The peak response of this detector-filter combination was at 468 nm with half-maximum points at 397 and 483 nm.
RESULTS AND DISCUSSION
When solutions of bilirubin bound to human serum albumin are exposed to light, the fastest reaction is configurational isomerization about the meso double bond between carbons 15 and 16 [configurational isomerization at the C-4-C-5 meso double bond does not occur when bilirubin is bound to human albumin (1 I)]. This reaction can be represented by:
where hu represents a photon of frequency U. The results in Table  1 demonstrate that the initial rate of this reaction, expressed as the inverse of the time required to convert 10% of the native bilirubin to the 42,15E isomer (I/T,& is dependent upon the intensity of irradiation falling within the absorption band of bilirubin (1400-soo). The correlation between these two parameters is 0.969.
The configurational isomerization reaction (Equation 1) is photochemically reversible (6, 12) and must compete with the corresponding reverse reaction (the 4E, 15E isomer is not formed in detectable amounts):
Thus, in a closed system, an equilibrium is eventually established. Because the two isomeric forms have overlapping, but not identical, absorption spectra (6), the position of this equilibrium (Equation 2) will depend upon the spectral distribution of the light source being used. With monochromatic irradiation, the percentage of the total bilirubin present as the 4Z,15E isomer at equilibrium ranged from 16% with 490 nm light to greater than 40% with 390 nm light (6) . The table gives the percentage of the total bilirubin present as the 42,15E isomer at equilibrium with the six phototherapy lamps. The greatest equilibrium concentration of 4 %, 15 E configurational isomer was achieved with the special blue lamp, which has a narrow spectral output centered at 445 nm (Fig. I) . Lower equilibrium concentrations were produced by the three fluorescent lamps with broad emission spectra [daylight, Vita-Lite, and blue (Fig. 1)) . A somewhat lower equilibrium concentration was produced by the tungsten-halogen lamp despite its rapid initial rate of isomerization. The least conversion of native bilirubin to the 4Z,15E isomer was achieved with the green lamp [recently used experimentally in the treatment of neonatal hyperbilirubinemia (1 8)], which has little emission falling within the absorption band of bilirubin (Fig. 1) . Table 1 shows the percentage of the total bilirubin present as the structural isomer lumirubin after 20 and 60 min of irradiation with the six phototherapy lamps. The greatest conversion of bilirubin to lumirubin was achieved by the two lamps (special blue and tungsten-halogen) with the greatest irradiance within the bilirubin absorption band. The green lamp, with the least emission in the 400 to 500 nm region, produced lumirubin at a rate comparable to that of the remaining three fluorescent lamps (daylight, Vita-Lite, and blue). This result is somewhat surprising. Some enhancement of the rate of lumirubin formation by the green lamp would be expected because this lamp forms the least 42,15E isomer. The 42,15E isomer is not a precursor of lumirubin ( 1 1 ) and its presence diminishes the rate of lumirubin formation both by reducing the concentration of native bilirubin and by acting as an internal filter. An additional enhancement of the rate of lumirubin formation by the green lamp would result if this photochemical reaction is favored by light at longer wavelengths. The action spectrum for conversion of bilirubin to lumirubin has not been measured and will be difficult to determine because of the competing and much more rapid formation of 4Z, 15 E-bilirubin. Recent studies indicate that lumirubin is formed directly from bilirubin and not from the 42,15E isomer (1 1). Therefore, the action spectrum for lumirubin formation in vitro is probably coincident with, or at least contained within, the absorption spectrum of bilirubin. This study provides the first comparison of the efficacy of clinically used phototherapy light sources in the biologically important configurational and structural isomerization reactions of bilirubin in vitro. These data cannot be extrapolated directly to in viro phototherapy because of the influence of the optical properties of the skin ( I ) , and because the relative contributions of configurational and structural isomerization to the therapeutic response to phototherapy are not known. The absorption of light by the skin will diminish the effective irradiance in vivo and thus diminish the initial rates of these reactions. In addition, light scattering preferentially attenuates the shorter wavelengths (1). and thereby alters the effective spectral distribution in vivo and the relative rates of lumirubin and 42.15E isomer formation. In particular. light sources such as the daylight lamp whose emission within the bilirubin absorption band contains a substantial contribution from shorter wavelengths would probably be less effective in \,fro than suggested by our in vitro results.
Certain conclusions can be drawn about the in vivo efficacy of commonly used phototherapy lamps based upon our in vitro data. The broad spectrum fluorescent lamps (daylight, Vita-Lite, and blue) and the green lamp produce the lowest rates of configurational and structural isomerization, and therefore are probably least effective in vivo. The special blue and the tungstenhalogen lamps produce rapid rates of isomerization and are therefore probably the most effective of lamps currently used clinically.
A recently completed clinical study suggests that lumirubin formation and excretion may be an important pathway for bilirubin elimination during phototherapy (Ennever et al., submitted). If lumirubin formation is important and if it is favored. as our in vitro data suggest. by longer wavelength light, then a more effective lamp for phototherapy would be one with a spectral output similar to that of the special blue with its emission band shifted or broadened on the longer wavelength side. t Calculated b! extrapolation from initial rate of configurational isomerization because final percentage of 4%,15E isomer was only 6.9.
